Results 131 to 140 of about 2,136 (183)

[Infections by OXA-48 carbapenemase-producing Enterobacteriaceae in surgical patients: antibiotic consumption and susceptibility patterns]. [PDF]

Rev Esp Quimioter, 2020
Mora-Guzmán I, Rubio-Perez I, Domingo-Garcia D, Martín-Pérez E.   +3 more
europepmc   +1 more source

Double-carbapenemase-producing Enterobacteriaceae: complete genome sequencing of isolates from hospitals in Paraguay, 2021. [PDF]

Rev Peru Med Exp Salud Publica
Melgarejo Touchet N, Weiler N, Busignani S, Orrego V, Duarte MJ, Martínez J, Dunjo P, Martínez Mora M, Kawabata A, Irala J, Brítez M, Escobar F, Gonzalez F, Riquelme C, Soilan B.   +14 more
europepmc   +1 more source

[Epidemiological characteristics of patients with carbapenemase-producing NDM Enterobacterales isolates in a high-complexity hospital]. [PDF]

Rev Esp Quimioter
Artiles-León CM, Rodríguez-Restrepo S, Torres-Jiménez IA, de Las Delicias Quintana-Estellés M, Viedma-Moreno E, Arrazola-Martínez P, Jaén-Herreros F, Sanz-Gallardo I, Suárez-García E, Craviotto-Vallejo A, de Miguel-García S.   +10 more
europepmc   +1 more source

Problemática de las enterobacterias productoras de carbapenemasas. Trabajo de revisión bibliográfica

, 2019
[ES] Las agencias internacionales de la salud, han alertado sobre el aumento preocupante de la resistencia a antibióticos en las últimas dos décadas. Gran parte de estas resistencias, se atribuyen a la familia de bacterias Enterobacteriaceae por su capacidad de desarrollar diferentes mecanismos que las hacen susceptibles cada vez a un menor número de ...
openaire   +1 more source

Clonal diversity of carbapenemase-producing Pseudomonas aeruginosa isolated from clinical samples in a third level hospital in Peru. [PDF]

Rev Peru Med Exp Salud Publica
Salvador-Lujan G, Cruz-Pio LE, Calla H, Rivera-Asencios D, Solís-Cayo L, García-de-la-Guarda R.   +5 more
europepmc   +1 more source

Emergence of KPC-31, a KPC-3 Variant Associated with Ceftazidime-Avibactam Resistance, in an Extensively Drug-Resistant ST235 Pseudomonas aeruginosa Clinical Isolate. [PDF]

Antimicrob Agents Chemother, 2022
Faccone D, de Mendieta JM, Albornoz E, Chavez M, Genero F, Echegorry M, Ceriana P, Mora A, Seah C, Corso A, Melano RG, Pasteran F.   +11 more
europepmc   +1 more source

[The β Carba® test can quickly determine the carbapenemases in the microbiology laboratory]. [PDF]

Rev Esp Quimioter
Serrano-Romero JM, Román-de-la-Torre A, Navarro-Marí JM, Gutiérrez-Fernández J.   +3 more
europepmc   +1 more source

[In vitro activity of delafloxacin against clinical isolates of carbapenem-resistant Pseudomonas aeruginosa in a stage prior to the clinical use of this drug]. [PDF]

Rev Esp Quimioter
García-Rivera C, Navarro M, Parra M, Sánchez Bautista A, Gómez I, Ventero MP, Rodríguez JC.   +6 more
europepmc   +1 more source

[Current microbiological aspects of community respiratory infection beyond COVID-19]. [PDF]

Rev Esp Quimioter, 2021
Cantón R.
europepmc   +1 more source